BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Subscribe
Contribute
Subscribe
Subscribe
Upstream
Related Topics
Bioreactors
Expression Platforms
Biochemicals/Raw Materials
Cell Culture Media
Microbial Cell Culture
Perfusion Cell Culture
Recent in
Upstream
See all
thumbnail
Expression Platforms
Empowering Biologic Breakthroughs: Transforming Tomorrow’s Healthcare Landscape Through Microbial-Based Development and Manufacturing
Empowering Biologic Breakthroughs: Transforming Tomorrow’s Healthcare Landscape Through Microbial-Based Development and Manufacturing
by
Rebekka Wuester
Mar 28, 2024
Downstream
Related Topics
Filtration
Viral Clearance
Separation/Purification
Chromatography
Recent in
Downstream
See all
thumbnail
Chromatography
Real-Time Monitoring of AAV CQAs in a Chromatographic Polishing Step
Real-Time Monitoring of AAV CQAs in a Chromatographic Polishing Step
by
BPI Contributor
Apr 9, 2024
1 Hr View
thumbnail
Chromatography
A Partnership in Innovation: Next-Generation Solutions for Affinity Chromatography
A Partnership in Innovation: Next-Generation Solutions for Affinity Chromatography
by
BPI Contributor
Mar 28, 2024
1 Hr View
Manufacturing
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Recent in
Manufacturing
See all
Artificial intelligence
Information Technology
Using Artificial Intelligence for Monoclonal Antibody Discovery
Using Artificial Intelligence for Monoclonal Antibody Discovery
by
William Whitford
Apr 17, 2024
thumbnail
Single Use
Enhancing Cell Viability Through Controlled Freezing
Enhancing Cell Viability Through Controlled Freezing
by
Brian Moloney
Mar 28, 2024
Analytical
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
See all
Business
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
Recent in
Business
See all
blue and purple mass of cells
Contract Services
Setting the Standard in Cell- and Gene-Therapy Manufacturing: Tackling Performance, Scalability, and Regulatory Compliance Challenges Together
Setting the Standard in Cell- and Gene-Therapy Manufacturing: Tackling Performance, Scalability, and Regulatory Compliance Challenges Together
by
Prity Bengani-Lutz,
Lorraine Borland
and 4 more
Apr 10, 2024
Therapeutic Modalities
Related Topics
Cell Therapies
Gene Therapies
MAb
Emerging Therapeutics
Personalized Medicine
Large Molecule Development
Vaccines
Recent in
Therapeutic Modalities
See all
Clean room worker using a computer
Emerging Therapeutics
The Evolution of Medicine: Empowering Healthcare for the Delivery of Advanced Therapies
The Evolution of Medicine: Empowering Healthcare for the Delivery of Advanced Therapies
by
Rohin Iyer,
Robert Brackner
Apr 10, 2024
Biomanufacturing scientists
Gene Therapies
Biologics Manufacturing from Gene to Product
Biologics Manufacturing from Gene to Product
by
Thilo Kamphausen,
Kai Pohlmeyer
Apr 10, 2024
BioProcess Insider
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
thumbnail
Facilities & Capacity
Kincell Bio to buy cell therapy NC plant from Imugene
Kincell Bio to buy cell therapy NC plant from Imugene
by
Millie Nelson
Apr 18, 2024
1 Min Read
thumbnail
Deal Making
Germfree acquires Orgenesis tech, inks deal to advance cell therapies
Germfree acquires Orgenesis tech, inks deal to advance cell therapies
by
Shreeyashi Ojha
Apr 18, 2024
1 Min Read
Home
Manufacturing
CMC Forums
CMC Forums
Advancing Vaccine Development with Novel Chromatography Solutions
Sponsored Content
Advancing Vaccine Development with Novel Chromatography Solutions
Advancing Vaccine Development with Novel Chromatography Solutions
by
Sirat Sikka,
Florian Durst
Sep 19, 2023
|
1 Min Read
BioProcess Insider Interview: Min Park, Chief Business Officer, Aton Biotech
Sponsored Content
BioProcess Insider Interview: Min Park, Chief Business Officer, Aton Biotech
BioProcess Insider Interview: Min Park, Chief Business Officer, Aton Biotech
by
BPI Contributor
Aug 21, 2023
Cell Lines Are the Foundation: A Methodical Approach to Derisking Outsourced Development and Improving Manufacturability of Novel Biologics
Cell Line Development
Cell Lines Are the Foundation: A Methodical Approach to Derisking Outsourced Development and Improving Manufacturability of Novel Biologics
Cell Lines Are the Foundation: A Methodical Approach to Derisking Outsourced Development and Improving Manufacturability of Novel Biologics
by
Jason Condon
Apr 20, 2023
Risk-Based Biologics: CMC Flexibilities in the EU Regulatory System
CMC Forums
Risk-Based Biologics: CMC Flexibilities in the EU Regulatory System
Risk-Based Biologics: CMC Flexibilities in the EU Regulatory System
by
David W. Murray
Mar 21, 2023
DNA to IND in 13 Months: A CMC Strategy for Bispecifics
Sponsored Content
DNA to IND in 13 Months: A CMC Strategy for Bispecifics
DNA to IND in 13 Months: A CMC Strategy for Bispecifics
by
Andrew Brown, PhD
Nov 16, 2022
20 Years of Chemistry, Manufacturing, and Controls Strategy. A Conversation About the CASSS CMC Forum Series
CMC Forums
20 Years of Chemistry, Manufacturing, and Controls Strategy. A Conversation About the CASSS CMC Forum Series
20 Years of Chemistry, Manufacturing, and Controls Strategy. A Conversation About the CASSS CMC Forum Series
by
Cheryl Scott,
Nadine M. Ritter
and 1 more
Aug 19, 2022
CMC Forums
CMC Strategies for Expedited Program Development — Regulatory Perspectives: Session 1 of a CMC Strategy Forum
CMC Strategies for Expedited Program Development — Regulatory Perspectives: Session 1 of a CMC Strategy Forum
May 20, 2022
by
Natalya Ananyeva,
David Robbins
CMC Forums
eBook: Creating CMC Strategies for Pandemics and Beyond — Perspectives on the Impact of the COVID-19 Pandemic
eBook: Creating CMC Strategies for Pandemics and Beyond — Perspectives on the Impact of the COVID-19 Pandemic
Nov 30, 2021
+4
by
Kim Wolfram,
Nina S. Cauchon
and 4 more